Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/3261630

Cancer Res. 1988 Sep 1 48 17 5007-10

Download in:

View as

General Info

PMID
3261630